13results
-
Press
SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023
-
Press
SK pharmteco to Expand Capabilities with Acquisition of Controlling Interest in CBM
-
Press
SK Inc.’s board of directors declares an interim dividend of KRW 1,500 per share
-
Press
SK pharmteco doubles viral vector production capacity in Europe
-
Press
SK Inc. Holds Annual General Meeting (AGM) of Shareholders
-
Press
SK Inc. hosts “SK Bio Night” in San Francisco to expand global partnerships
-
Press
SK Inc. Showcases Technologies That Will Lead to a Carbon Neutral Future at CES 2023
-
Press
SK Inc. expands CDMO capacity, accelerating its advance to the global market
-
Press
SK Inc., declared an interim dividend of KRW1,500 per share